HC Wainwright Reaffirms “Buy” Rating for CG Oncology (NASDAQ:CGON)
HC Wainwright restated their buy rating on shares of CG Oncology (NASDAQ:CGON – Free Report) in a research report released on Tuesday,Benzinga reports. They currently have a $75.00 price objective on the stock. Other equities research analysts also recently issued research reports about the stock. Royal Bank of Canada restated an “outperform” rating and issued […]
HC Wainwright restated their buy rating on shares of CG Oncology (NASDAQ:CGON – Free Report) in a research report released on Tuesday,Benzinga reports. They currently have a $75.00 price objective on the stock. Other equities research analysts also recently issued research reports about the stock. Royal Bank of Canada restated an “outperform” rating and issued […]
